Cargando…
A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics
The development of therapeutic monoclonal antibodies through mouse immunization often originates drug candidates that are not cross-reactive to the mouse ortholog. In such cases, and particularly in oncology, drug efficacy studies are performed on human tumor xenografts or with “surrogate” anti-mous...
Autores principales: | Costa, Maria José, Kudaravalli, Jyothirmayee, Liu, Wen-Hui, Stock, Jeffrey, Kong, Sophanna, Liu, Shu-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858835/ https://www.ncbi.nlm.nih.gov/pubmed/29554149 http://dx.doi.org/10.1371/journal.pone.0194688 |
Ejemplares similares
-
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
por: Costa, Maria José, et al.
Publicado: (2019) -
Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
por: Sieber, Brendan, et al.
Publicado: (2022) -
Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis
por: Herzig, Daniela S, et al.
Publicado: (2012) -
Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes
por: Xu, Tingting, et al.
Publicado: (2020) -
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
por: Kashyap, Manoj K., et al.
Publicado: (2017)